Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover which index funds have top Treynor ratio and why this metric matters for risk-adjusted returns. Learn evaluation tips and rankings.
27,509 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
In a market eager for AI breakthroughs, one tech stock with eyes stands out as a long-term buy. This article breaks d...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...
Investors are watching Friday’s April payroll report for signs that businesses really starting hire signals a broader...
Michigan drivers are feeling the pinch as gas prices rise. This article explains the root causes, the economic ripple...
Rigetti’s towering market value vs. tiny revenue draws scrutiny as major players like Alphabet and IonQ emerge as sma...
HSBC upgraded Cisco to Buy and lifted the price target as the company moves toward a $6 billion AI revenue goal for F...
Lawmakers unveil a bill to raise the ethanol blend to 15% year-round, hoping to shave pump costs and support farmers....
Zillow has filed for a federal injunction to stop MRED from cutting off IDX and VOW data feeds, while MRED presses fo...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
Barnes Noble clarifies Bookseller’s AI policy, saying it will not ban AI-written titles but will require clear labeli...